A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to ...

As the Trump administration issued an abrupt pause to federal financial assistance, the move threatened billions in grants ...

"We need to know what adverse events are. We need to understand the safety of every drug, mifepristone, and every other drug.

Pharmaron, a Chinese biotech firm, is currently using hundreds of thousands of taxpayer dollars to test pharmaceuticals on up ...

Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...

Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...

The agency expects “additional guidance” this week on the communications freeze — which unleashed confusion about whether ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

Major academic research institutions and medical schools in the Philadelphia region are allotted $1.7 billion in NIH funding.

A trio of Democrats on Monday called on the Trump administration to restore full operations at the National Institutes of ...

An unprecedented federal ban on scientific meetings halts research progress, sparking widespread concern across the ...